Magenta Therapeutics MGTA 深 滬
已收盤 09-11 16:00:00 美东时间
0.6996
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.6996
- 總市值 4244.10万
- 52周最高 28.96
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 5.136
- 委 比 0.00%
- 總股本 6066.47万
- 歷史最高 336.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 5.136
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dianthus Therapeutics reports FY results
Dianthus Therapeutics press release (NASDAQ:DNTH): Net loss for the year ended December 31, 2023 was $43.6 million or $8.45 net loss per share (basic and diluted) compared to $28.5 million or $32.57 ...
2024-03-22 05:16
2023，那些悄悄消失的ADC管线
真正的离开，从来都是悄无声息的。 据智药局监测，2023年全球至少有16条ADC临床管线终止研发，涉及9家药企，这些管线悄悄从官网消失了，同时并未出现公开转让或...
2023-12-19 18:57
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.
2023-09-12 01:38
当ADC管线接二连三的翻车，谁的美梦碎了？
转自：药时空 ADC的火热刺激着一批又一批玩家进场，一方面市场对于药企试错的容忍度不断降低，对药物的安全性和疗效提出了更高要求。 另一方面，对企业而言，药物未...
2023-08-13 00:01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED
NEW YORK, May 4, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or b...
2023-05-04 12:00
Magenta Sets Up Dianthus Merger After Stopping Blood Cancer Trial Due To Patient Death
Magenta Therapeutics Inc (NASDAQ: MGTA) and privately-held Dianthus Therapeutics Inc have announced to merge in an
2023-05-04 02:19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Immunogen (NASDAQ:IMGN) shares rose 126.1% to $11.76 during Wednesday'...
2023-05-04 01:31
Magenta Therapeutics and Dianthus Therapeutics Announced Merger Agreement
Magenta Therapeutics, Inc. (NASDAQ: MGTA) ("Magenta") and Dianthus Therapeutics, Inc.
2023-05-03 19:34
Magenta Therapeutics, Inc. 预计 FY2025 每股收益为0.02美元（纳斯达克股票代码：MGTA）
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – HC Wainwright issued th...
2023-03-27 15:03
Magenta Therapeutics, Inc. Forecasted to Earn FY2025 Earnings of $0.02 Per Share (NASDAQ:MGTA)
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – HC Wainwright issued th...
2023-03-27 15:03
